ARTELO BIOSCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ARTELO BIOSCIENCES, INC. (ARTL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.27 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.37M shares, a 20338.51% increase year-over-year.
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 50.75K shares, a 69.63% decline year-over-year.
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 167.12K shares, a 99.98% decline year-over-year.
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 767.76M shares, a 25.39% increase year-over-year.
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 583.16K shares.
- ARTELO BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 486.18M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.27M shares 10-Q · filed 2026-08-12 | ||||||||
| 2026-03-31 | 10.37M shares 10-Q · filed 2026-05-14 | ||||||||
| 2025-12-31 | 542.26K shares 8-K · filed 2026-03-17 | 1.63M shares 10-K · filed 2026-02-24 | |||||||
| 2025-09-30 | 973.93K shares 10-Q · filed 2025-11-12 | ||||||||
| 2025-06-30 | 342.89K shares 10-Q · filed 2026-08-12 | 1.03M shares 10-Q · filed 2025-08-13 | |||||||
| 2025-03-31 | 50.75K shares 10-Q · filed 2026-05-14 | 913.50K shares 10-Q · filed 2025-05-13 | |||||||
| 2024-12-31 | 50.81K shares 8-K · filed 2026-03-17 | 913.50K shares 10-K · filed 2025-03-03 | |||||||
| 2024-09-30 | 150.50K shares 10-Q · filed 2025-11-12 | 903.00K shares 10-Q · filed 2024-11-12 | |||||||
| 2024-06-30 | 150.50K shares 10-Q · filed 2025-08-13 | 903.00K shares 10-Q · filed 2024-08-13 | |||||||
| 2024-03-31 | 167.12K shares 8-K · filed 2025-07-11 | 1.00M shares 10-Q · filed 2024-05-13 | |||||||
| 2023-12-31 | 126.99K shares 8-K · filed 2025-07-11 | 761.74K shares 10-K · filed 2024-03-25 | |||||||
| 2023-09-30 | 772.42K shares 10-Q · filed 2024-11-12 | ||||||||
| 2023-06-30 | 771.43K shares 10-Q · filed 2024-08-13 | ||||||||
| 2023-03-31 | 767.76M shares 10-Q · filed 2023-05-11 | ||||||||
| 2022-12-31 | 583.16K shares 10-K · filed 2024-03-25 | 583.16M shares 10-K · filed 2023-03-31 | |||||||
| 2022-09-30 | 583.16K shares 10-Q · filed 2023-11-13 | ||||||||
| 2022-06-30 | 584.77K shares 10-Q · filed 2023-08-10 | ||||||||
| 2022-03-31 | 612.32M shares 10-Q · filed 2023-05-11 | ||||||||
| 2021-12-31 | 629.55M shares 10-K · filed 2023-03-31 | ||||||||
| 2021-08-31 | 486.18M shares 10-K · filed 2023-03-31 | ||||||||
| 2021-05-31 | 7.40M shares 10-Q · filed 2021-07-12 | ||||||||
| 2021-02-28 | 7.72M shares 10-Q · filed 2021-04-13 | ||||||||
| 2020-11-30 | 12.86M shares 10-Q · filed 2021-01-14 | ||||||||
| 2020-05-31 | 2.62M shares 10-Q · filed 2021-07-12 | ||||||||
| 2020-02-29 | 2.62M shares 10-Q · filed 2021-04-13 | ||||||||
| 2019-11-30 | 2.57M shares 10-Q · filed 2021-01-14 | ||||||||
| 2019-05-31 | 782.35K shares 10-Q · filed 2020-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |